Advanced Intake Fact Sheet
The industry’s must trusted safety system just got better.
Why cloud is the only modern option for efficient, high-volume Safety data processing
Sam Wallis, Head of ICSR Case Processing within the Worldwide Patient Safety Operations at Bristol Myers Squibb, will join a Breakthrough 2024 panel discussion on the reality of transitioning Safety/Regulatory systems to the cloud. Here, he provides a glimpse into BMS’s own journey, which he’ll share candidly during the Day 1 debate.
Why Now Is the Right Time to Invest in Your First Drug Safety System
Small and emerging biopharma like yours face a crucial question ...
What Does Approachable Automation Mean for Drug Safety Platforms?
There’s no doubt that the pharmaceutical industry is well into ...
Unlocking the Next Generation of Reporting and Analytics for Drug Safety Intelligence
The Future of Drug Safety Intelligence The future of safety ...
Vaccine Safety in the Public Eye: How COVID-19 Brought Pharmacovigilance Center-Stage
The coronavirus pandemic ushered in a new era of public ...
Virtual Presentations, Real Results – “Leveraging Automation in PV” Presented at DIA 2020 Annual Meeting
Organizations currently utilizing manual pharmacovigilance processing understand that it involves many time-consuming manual activities, but ArisGlobal’s LifeSphere Multivigilance 10 is the future of pharmacovigilance.
Turnkey Configuration and Next Level Standardization: ArisGlobal Works with Industry Leaders to Optimize Out-of-the-Box Safety Workflow
As part of our commitment to providing the most robust ...
Think Global, Watch Local: The DIA 2020 Annual Meeting Is Now Virtual, and ArisGlobal Is All In
The DIA 2020 Annual Meeting Is Now Virtual. ArisGlobal will be front and center with presentations covering both Safety and Clinical perspectives in Life Sciences process management.
The Silent Hero: How Advances in Today’s Technology Can Prevent, Assess, Detect, Treat and Predict Health Issues
Advanced computing methods can be used for safety monitoring and early detection of potential signals of vaccine-related adverse events. These methods work by mining open-access active-moiety databases and vast scientific literature with clinical case studies.
